Home
Mail
News
Sport
Finance
Celebrity
Style
Weather
Mobile
Messenger
Movies
More
Yahoo
Mail
News
Market Data
Crypto
Bank of England
Money Matters
Property
Top Stocks
Work & Management
Industry News
Brexit
My Portfolio
My Screeners
Watchlists
Videos
UK markets closed
FTSE 100
8,420.26
-18.39
(-0.22%)
FTSE 250
20,749.90
-72.94
(-0.35%)
AIM
794.02
+1.52
(+0.19%)
GBP/EUR
1.1678
+0.0023
(+0.20%)
GBP/USD
1.2706
+0.0035
(+0.28%)
Bitcoin GBP
52,707.79
+1,227.93
(+2.39%)
Property
9 houses with great-looking gardens
Check out these homes if inspiring outside space tops your property wish list
ESSA Pharma Inc. (EPIX)
NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
5.70
-0.55
(-8.80%)
At close: 04:00PM EDT
5.98
+0.28
(+4.91%)
After hours:
07:24PM EDT
Summary
Chart
Conversations
Statistics
Historical data
Profile
Financials
Analysis
Options
Holders
Sustainability
Show
:
Income statement
Balance sheet
Cash flow
Annual
Quarterly
Income statement
All numbers in thousands
Breakdown
ttm
30/09/2023
30/09/2022
30/09/2021
30/09/2020
Total revenue
0
0
0
0
0
Operating expenses
Research development
23,052
21,323
24,415
24,259
12,146
Selling general and administrative
11,859
11,366
12,280
12,775
11,264
Total operating expenses
34,147
32,134
36,960
37,144
23,520
Operating income or loss
-34,147
-32,134
-36,960
-37,144
-23,520
Interest expense
2.648
6.942
13.746
22.22
618.109
Total other income/expenses net
862.096
6.529
22.039
90.983
-155.707
Income before tax
-27,734
-26,581
-35,215
-36,840
-23,734
Income tax expense
0
1.6
-111.821
-34.349
-288.647
Income from continuing operations
-27,734
-26,582
-35,103
-36,805
-23,445
Net income
-27,734
-26,582
-35,103
-36,805
-23,445
Net income available to common shareholders
-27,734
-26,582
-35,103
-36,805
-23,445
Basic EPS
-0.60
-0.60
-0.80
-0.96
-1.04
Diluted EPS
-0.60
-0.60
-0.80
-0.96
-1.04
Basic average shares
44,090
44,090
44,038
38,480
22,444
Diluted average shares
44,090
44,090
44,038
38,480
22,444
Data disclaimer
Help
Suggestions
Terms
and
Privacy Policy
Privacy dashboard
About our ads
© 2024 Yahoo. All rights reserved.